Trial · NCT01268683
Outcomes20
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 20
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Rate of Enrollment | Day 1 | Months | NUMBER | |
| PRIMARY | Percentage of Enrolled Participants to Screened Participants | Day 1 | Percentage of Participants | NUMBER | |
| PRIMARY | Percentage of Participants Completing 90-Day Follow-Up | Day 90 | Percentage of Participants | NUMBER | |
| PRIMARY | Percentage of Dose Reductions/ Dose Suspensions | Up to Day 3 | Percentage of Participants | NUMBER | |
| PRIMARY | Percentage of Participants With All Four MRI Assessments Per Protocol | Up to Day 3 | Percentage of Participants | NUMBER | |
| PRIMARY | Number of MRI Assessments Per Participant | Up to Day 3 | Number of MRIs | MEAN | |
| PRIMARY | Percentage of Participants Requiring One or More Hypoglycemia Treatments | Up to Day 4 | Percentage of Participants | NUMBER | |
| PRIMARY | Percentage of Participants With Pre-specified Adverse Events Associated With Glyburide According to Protocol | Up to Day 4 | Percentage of Participants | NUMBER | |
| SECONDARY | Number of Participants With Adverse Events and Serious Adverse Events | Up to Day 90 | Number of Participants | NUMBER | |
| SECONDARY | Infarcted Hemisphere Volume | Baseline, Day 1, Day 2, and Day 3 | The number analyzed varies due to only MRIs of good quality being analyzed. | Centimeters cubed (cm^3) | MEAN |
| SECONDARY | Absolute Diffusion Weighted Imaging (DWI) Lesion Volume | Baseline, Day 1, Day 2, and Day 3 | The number analyzed varies due to only MRIs of good quality being analyzed. | Cm^3 | MEAN |
| SECONDARY | Change From Baseline in DWI Lesion Volume | Baseline, Day 1, Day 2, and Day 3 (Day 3 reported) | Cm^3 | MEAN | |
| SECONDARY | Midline Shift | Baseline, Day 1, Day 2, and Day 3 | The number analyzed varies due to only MRIs of good quality being analyzed. | Millimeters (mm) | MEAN |
| SECONDARY | Ipsilateral Ventricle Volume | Baseline, Day 1, Day 2, and Day 3 | The number analyzed varies due to only MRIs of good quality being analyzed. | Cm^3 | MEAN |
| SECONDARY | Frequency of Hemorrhagic Events | Day 1, Day 2, and Day 3 | Number of Events | NUMBER | |
| SECONDARY | National Institute of Health Stroke Scale (NIHSS) Score | Baseline, Day 1, Day 2, Day 3, and Day 7 | Score on a Scale | MEAN | |
| SECONDARY | Glasgow Coma Scale (GCS) Score | Baseline, Day 1, Day 2, Day 3, and Day 7 | Score on a scale | MEAN | |
| SECONDARY | Full Outline of UnResponsiveness (FOUR) Score | Baseline, Day 1, Day 2, Day 3, and Day 7 | Score on a Scale | MEAN | |
| SECONDARY | Number of Participants Requiring Decompressive Craniectomy (DC) | Up to Day 90 | Number of Participants | NUMBER | |
| SECONDARY | Number of Participants With a Modified Rankin Scale (mRS) Score ≤ 4 | Day 30, Day 90 | The number analyzed varies due to participants not completing follow up. | Number of Participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01268683/outcomes